The CDK1 inhibitory kinase MYT1 in DNA damage checkpoint recovery

Oncogene

Volumn 32, Issue 40, 2013, Pages 4778-4788

  Chow, J P H ^a   Poon, R Y C ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

cell cycle; checkpoint; ionizing radiation

Indexed keywords

7 HYDROXYSTAUROSPORINE; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CDK1 INHIBITORY KINASE MYT1; CHECKPOINT KINASE 1 INHIBITOR; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; DNA; MK 1775; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE INHIBITOR; RO 3306; UNCLASSIFIED DRUG; WEE1 INHIBITOR; WEE1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL CYCLE CHECKPOINT; CELL FUNCTION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA DAMAGE CHECKPOINT; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; MICROSCOPY; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; TIME LAPSE MICROSCOPY; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; BASE SEQUENCE; CDC2 PROTEIN KINASE; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; DNA DAMAGE; DNA PRIMERS; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FEMALE; HELA CELLS; HUMANS; MICE; MICE, INBRED BALB C; NUCLEAR PROTEINS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTEIN-TYROSINE KINASES; RNA INTERFERENCE; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84885179495     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.504     Document Type: Article

References (36)

1. Fung TK, Poon RYC. A roller coaster ride with the mitotic cyclins. Semin Cell Dev Biol 2005; 16: 335-342.
2. Booher RN, Holman PS, Fattaey A. Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity. J Biol Chem 1997; 272: 22300-22306.
3. Parker LL, Piwnica-Worms H. Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science 1992; 257: 1955-1957.
4. Van Vugt MA, Bras A, Medema RH. Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol Cell 2004; 15: 799-811.
5. Watanabe N, Arai H, Iwasaki J, Shiina M, Ogata K, Hunter T et al. Cyclin-dependent kinase (CDK) phosphorylation de stabilizes somatic Wee1 via multiple pathways. Proc Natl Acad Sci USA 2005; 102: 11663-11668.
6. Watanabe N, Arai H, Nishihara Y, Taniguchi M, Watanabe N, Hunter T et al. M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP. Proc Natl Acad Sci USA 2004; 101: 4419-4424.
7. Katayama K, Fujita N, Tsuruo T. Akt/protein kinase B-dependent phosphorylation and inactivation of WEE1Hu promote cell cycle progression at G2/M transition. Mol Cell Biol 2005; 25: 5725-5737.
8. Wells NJ, Watanabe N, Tokusumi T, Jiang W, Verdecia MA, Hunter T. The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G(2)/M progression. J Cell Sci 1999; 112: 3361-3371.
9. Nakajima H, Toyoshima-Morimoto F, Taniguchi E, Nishida E. Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate. J Biol Chem 2003; 278: 25277-25280.
10. Stumpff J, Duncan T, Homola E, Campbell SD, Su TT. Drosophila Wee1 kinase regulates Cdk1 and mitotic entry during embryogenesis. Curr Biol 2004; 14: 2143-2148.
11. Nakajima H, Yonemura S, Murata M, Nakamura N, Piwnica-Worms H, Nishida E. Myt1 protein kinase is essential for Golgi and ER assembly during mitotic exit. J Cell Biol 2008; 181: 89-103.
12. Nakajo N, Yoshitome S, Iwashita J, Iida M, Uto K, Ueno S et al. Absence of Wee1 ensures the meiotic cell cycle in Xenopus oocytes. Genes Dev 2000; 14: 328-338.
13. Ruiz EJ, Hunt T, Nebreda AR. Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation. Mol Cell 2008; 32: 210-220.
14. Okumura E, Fukuhara T, Yoshida H, Hanada Si S, Kozutsumi R, Mori M et al. Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. Nat Cell Biol 2002; 4: 111-116.
15. Chen Y, Poon RYC. The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability. Front Biosci 2008; 13: 5016-5029.
16. Jin P, Gu Y, Morgan DO. Role of inhibitory CDC2 phosphorylation in radiationinduced G2 arrest in human cells. J Cell Biol 1996; 134: 963-970.
17. O?Connell MJ, Raleigh JM, Verkade HM, Nurse P. Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J 1997; 16: 545-554.
18. Van Vugt MA, Medema RH. Getting in and out of mitosis with Polo-like kinase-1. Oncogene 2005; 24: 2844-2859.
19. Karlsson-Rosenthal C, Millar JB. Cdc25: Mechanisms of checkpoint inhibition and recovery. Trends Cell Biol 2006; 16: 285-292.
20. On KF, Chen Y, Ma HT, Chow JP, Poon RYC. Determinants of mitotic catastrophe on abrogation of the G2 DNA damage checkpoint by UCN-01. Mol Cancer Ther 2011; 10: 784-794.
21. Mizuarai S, Yamanaka K, Itadani H, Arai T, Nishibata T, Hirai H et al. Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor. Mol Cancer 2009; 8: 34.
22. Chow JP, Poon RYC, Ma HT. Inhibitory phosphorylation of cyclin-dependent kinase 1 as a compensatory mechanism for mitosis exit. Mol Cell Biol 2011; 31: 1478-1491.
23. Krek W, Nigg EA. Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: Evidence for a double block to p34cdc2 kinase activation in vertebrates. EMBO J 1991; 10: 3331-3341.
24. Wang Y, de cker SJ, Sebolt-Leopold J. Knockdown of Chk1, Wee1 and Myt1 by RNA interference abrogates G2 checkpoint and induces apoptosis. Cancer Biol Ther 2004; 3: 305-313.
25. Yam CH, Siu WY, Lau A, Poon RYC. de gradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2. J Biol Chem 2000; 275: 3158-3167.
26. Chan YW, Ma HT, Wong W, Ho CC, On KF, Poon RYC. CDK1 inhibitors antagonize the immediate apoptosis triggered by spindle disruption but promote apoptosis following the subsequent rereplication and abnormal mitosis. Cell Cycle 2008; 7: 1449-1461.
27. Chan YW, Chen Y, Poon RYC. Generation of an indestructible cyclin B1 by caspase-6-dependent cleavage during mitotic catastrophe. Oncogene 2009; 28: 170-183.
28. Siu WY, Arooz T, Poon RYC. Differential responses of proliferating versus quiescent cells to adriamycin. Exp Cell Res 1999; 250: 131-141.
29. Chen Y, Chow JP, Poon RY. Inhibition of Eg5 acts synergistically with checkpoint abrogation in promoting mitotic catastrophe. Mol Cancer Res 2012; 10: 626-635.
30. Liu F, Stanton JJ, Wu Z, Piwnica-Worms H. The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. Mol Cell Biol 1997; 17: 571-583.
31. Ma HT, Tsang YH, Marxer M, Poon RYC. Cyclin A2-cyclin-dependent kinase 2 cooperates with the PLK1-SCFbeta-TrCP1-EMI1-anaphase-promoting complex/cyclosome axis to promote genome reduplication in the absence of mitosis. Mol Cell Biol 2009; 29: 6500-6514.
32. Chow JP, Siu WY, Ho HT, Ma KH, Ho CC, Poon RYC. Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints. J Biol Chem 2003; 278: 40815-40828.
33. Chan YW, On KF, Chan WM, Wong W, Siu HO, Hau PM et al. The kinetics of p53 activation versus cyclin E accumulation underlies the relationship between the spindle-assembly checkpoint and the postmitotic checkpoint. J Biol Chem 2008; 283: 15716-15723.
34. Yam CH, Siu WY, Kaganovich D, Ruderman JV, Poon RYC. Cleavage of cyclin A at R70/R71 by the bacterial protease OmpT. Proc Natl Acad Sci USA 2001; 98: 497-501.
35. Poon RYC, Toyoshima H, Hunter T. Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol Biol Cell 1995; 6: 1197-1213.
36. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989; 24: 148-154.